Table 2 Pathogens used in this study

1

HCV 1b 5’UTR-plasmid

Constructed by Tsingke Biotech (Beijing, China)

1

P

2

HCV 2a 5’UTR-plasmid

Constructed by Tsingke Biotech (Beijing, China)

1

P

3

HCV 3b 5’UTR-plasmid

Constructed by Tsingke Biotech (Beijing, China)

1

P

4

HCV 6a 5’UTR -plasmid

Constructed by Tsingke Biotech (Beijing, China)

1

P

5

HCV 3a 5’UTR -plasmid

Constructed by Tsingke Biotech (Beijing, China)

1

P

6

HCV clinical samples

2nd GZUTCM

6

P

7

Hepatitis B virus

2nd GZUTCM

1

N

8

Human immunodeficiency virus

GZCCL

1

N

9

Epstein-Barr virus

2nd GZUTCM

1

N

10

Coxsackie virus CAV16

GZCDC

1

N

11

Human papillomavirus

GZCCL

1

N

12

Human enterovirus EV71

GZCDC

1

N

13

Influenza A virus

GZCDC

1

N

14

Influenza B virus

GZCDC

1

N

15

Cryptococcus neoformans

2nd GZUTCM

1

N

16

Enterococcus faecium

2nd GZUTCM

1

N

17

Salmonella enteritidis

2nd GZUTCM

1

N

18

Shigella bogdii

2nd GZUTCM

1

N

19

Staphylococcus aureus

ATCC25923

1

N

20

Streptococcus pyogenes

2nd GZUTCM

1

N

21

Streptococcus pneumoniae

2nd GZUTCM

1

N

22

Escherichia coli

ATCC8739

1

N

23

Pseudomonas aeruginosa

ATCC27853

1

N

24

Klebsiella pneumoniae

ATCC700603

1

N

25

Mycobacterium tuberculosis

GZCDC

1

N

26

Brucella

GZCDC

1

N